Why Pharma’s Anti-Tampering Strategies Don’t Work: Dr. Roger Johnston

“We’ve never seen what we would consider effective tamper-detection for a drug product,” says Dr. Roger Johnston, head of the Vulnerability Assessment Team as Los Alamos National Laboratories. In this exclusive interview,

Johnston gives us the ten top failings of anti-tampering efforts, and solutions for improvement. Also, click the “Download Now” button at the end of the
article to obtain Johnston’s PowerPoint presentation on improving tamper detection systems.

Why Pharma’s Tamper-Evident Packaging Strategies Don’t Work _ Pharmaceutical Manufacturing